Background A number of studies have shown poorer survival among cancer patients with
comorbidity. Several mechanisms may underlie this finding. In this review we summarize the …

INTRODUCTION: Survival after breast cancer is determined by disease related factors such
as stage at diagnosis, patient characteristics, eg, age, and treatment. AIM: To review …

The authors evaluated the prognostic effects of obesity and weight change after breast
cancer diagnosis. A total of 5042 breast cancer patients aged 20–75 were identified through …

Background It is generally accepted that patients with breast cancer metastases have very
poor survival. Metastatic breast cancer patients can be considered a heterogeneous …

Purpose The sequelae of cancer treatment may increase systemic inflammation and create
a phenotype at increased risk of functional decline and comorbidities, leading to premature …

Background Patients with comorbidities do not receive optimal treatment for their cancer,
leading to lower cancer survival. Information on individual comorbidities is not …

Background The evaluation of comorbidity is of increasing importance in patients with
hematologic disorders. Patients and methods In the present study, the influence of …

Breast cancer is the most common invasive cancer among women in developed countries.
Obesity is a major risk factor for breast cancer recurrence and mortality in both pre-and …

Purpose: We evaluated associations among comorbidity, toxicity, time to relapse (TTR), and
overall survival (OS) in older women with early-stage breast cancer receiving adjuvant …

To investigate associations between comorbidity burden, management, and mortality in
women with breast cancer. A total of 42,646 women diagnosed with breast cancer between …